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While the past genome-wide association study (GWAS) for autoimmune thyroid diseases 
(AITDs) was done in Caucasians, a recent GWAS in Caucasian patients with both AITD 
and type 1 diabetes [a variant of autoimmune polyglandular syndrome type 3 (APS3v)] 
identified five non-HLA genes: BCL2L15, MAGI3, PHTF1, PTPN22, and GPR103. The 
aim of our study was to replicate these associations with AITD in a Japanese population. 
Since analyzing the rs2476601 single-nucleotide polymorphism (SNP) within the PTPN22 
gene revealed no polymorphism in the Japanese, we analyzed four SNPs, rs2358994 (in 
BCL2L15), rs2153977 (in MAGI3), rs1111695 (in PHTF1), and rs7679475 (in GPR103) 
genotypes in a case–control study based on 447 Japanese AITD patients [277 Graves’ 
disease (GD) and 170 Hashimoto’s thyroiditis (HT) patients] and 225 matched Japanese 
controls using the high-resolution melting and unlabeled probe methods. Case–control 
association studies were performed using the χ2 and Fisher’s exact tests with Yates 
correction. The G allele of rs7679475 (A/G) was associated with HT compared with 
controls [P = 0.022, odds ratio (OR) = 0.69]. GD showed no significant associations 
with any SNPs. However, when patients with GD were stratified according to Graves’ 
ophthalmopathy (GO), the G allele of rs2358994 (A/G) was associated with GO vs. 
controls (P = 0.018, OR = 1.52). These findings suggest that in the Japanese popula-
tion the GPR103 gene may contribute to the pathogenesis of HT. Moreover, this study 
demonstrated that the SNP rs2358994 within BCL2L15 gene is associated with GO in 
the Japanese population.
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inTrODUcTiOn
Autoimmune thyroid diseases (AITDs), including Graves’ disease (GD) and Hashimoto’s thyroiditis 
(HT), are among the most common human autoimmune diseases. The prevalence in Caucasians is 
1% (1, 2), and the prevalence in Japanese is not known. GD is characterized clinically by hyperthy-
roidism, diffuse goiter, and the presence of thyrotropin receptor (TSHR) antibodies. Some patients 
develop extrathyroidal manifestations, mainly ophthalmopathy and dermopathy [reviewed by 
Davies (3)]. Stimulatory TSHR autoantibodies are directly responsible for hyperthyroidism in GD. 
However, despite their contrasting clinical presentations, GD and HT share many common features, 
including the presence of autoantibodies to thyroid peroxidase and/or thyroglobulin, but rarely to 
the TSHR (3–5).
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The pathogenesis of AITDs is thought to involve several risk 
factors, including genetic risk factors [reviewed in Ref. (6)] and 
environmental triggers, such as cigarette smoking, iodine intake, 
and infection (7, 8) [reviewed by Davies (3)]. However, the 
evidence for interactions between hereditary factors and envi-
ronmental influences appears to be much stronger for cigarette 
smoking and iodine intake than for infections (8).
While the past genome-wide association study (GWAS) for 
AITDs was done in Caucasians, Lombardi et al. identified three 
new single-nucleotide polymorphisms (SNPs) on chromosome 
3q that are associated with GD in Italian patients indicating 
potential GD susceptibility genes in this locus (9). Recently, 
Immunochip genetic association analysis identified 30 SNPs 
in several genes that were significantly associated with Young-
Age-of-Onset GD, including major histocompatibility complex 
class I and class II genes, BTNL2, NOTCH4, TNFAIP3, and 
CXCR4 (10).
Moreover, the first GWAS performed in patients that 
developed both type 1 diabetes (T1D) and AITD [a variant 
of autoimmune polyglandular syndrome type 3 (APS3v)] was 
reported (11). Indeed, the co-occurrence of T1D and AITD 
in the same individual is classified as a variant of the autoim-
mune APS3v. They identified multiple signals within the HLA 
region, and conditioning studies suggested that a few of them 
contributed independently to the strong association of the 
HLA locus with APS3v (11). Outside the HLA region, vari-
ants in G protein-coupled receptor 103 (GPR103) located on 
chromosome 4q27, a gene not suggested by previous studies 
of APS3v, T1D, or AITD, showed genome-wide significance 
(P  <  5  ×  10−8) (11). Moreover, a locus on 1p13 containing 
four genes [B-cell lymphoma 2-like protein 5 (BCL2L15), 
membrane-associated guanylate kinase, WW and PDZ domain-
containing 3 (MAGI3), putative homeodomain transcription 
factor 1 (PHTF1), and protein tyrosine phosphatase non-
receptor type 22 (PTPN22)] showed genome-wide significant 
associations (11). Because of possible genetic heterogeneity 
between different ethnic groups, we aimed to replicate in the 
Japanese population the associations between AITD and the 
four SNPs, rs2358994 (in BCL2L15), rs2153977 (in MAGI3), 
rs1111695 (in PHTF1), and rs7679475 (in GPR103), recently 
reported in Caucasians. Types of all these SNPs we studied 
are nonsense. Since analyzing the rs2476601 SNP within the 
PTPN22 gene revealed no polymorphism in the Japanese, we 
did not analyze it in the present study.
MaTerials anD MeThODs
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Four hundred forty-seven unrelated Japanese AITD patients 
(age range, 30–80 years) were studied. There were a total of 277 
GD patients (69 males and 208 females) and 170 HT patients 
(17 males and 153 females). Of the 277 GD patients, 89 (32.1%) 
had Graves’ ophthalmopathy (GO).
Clinical Assessment
Graves’ disease was diagnosed based on clinical symptoms and 
biochemical confirmation of hyperthyroidism, including diffuse 
goiter, elevated radioactive iodine uptake, and elevated thyroid 
hormone levels. Ophthalmopathy was classified according to 
the system recommended by the American Thyroid Association 
(ATA) Committee (12). Eighty-nine of the GD patients showed 
ophthalmopathy defined as ATA class III or greater and were clas-
sified as GO. HT patients had documented clinical and biochemi-
cal hypothyroidism requiring thyroid hormone replacement 
therapy and showed autoantibodies against thyroid peroxidase 
with or without antibodies against thyroglobulin.
Controls
Two hundred twenty-five age- and sex-matched healthy Japanese 
volunteers (79 males and 146 females; age range, 34–72  years) 
served as controls in our association studies. All controls had no 
personal or family history of any autoimmune disease.
snP Typing
DNA was extracted from whole blood using the Puregene kit 
(Gentra Systems, Minneapolis, MN, USA). Four SNPs (rs2358994, 
rs2153977, rs1111695, and rs7679475) were genotyped by the 
high-resolution melting and unlabeled probe methods using 
LightScanner® (Idaho Technology Inc., Salt Lake City, UT, USA) 
based on the manufacture’s protocol.
statistical analysis
Case–control analysis and Hardy–Weinberg equilibrium (HWE) 
test of SNP were performed using SNPALyze ver. 7.0 (Dynacom, 
Yokohama, Japan) (13). Differences in the allele frequencies 
between the groups were analyzed using the chi-square test for 
two by two and two by three and Fisher’s exact test with Yates 
correction. The odds ratio (OR) was calculated using the modi-
fied method of Woolf (14). A P-value of <0.05 was considered 
statistically significant. HWE tests were carried out for all loci 
among subjects and controls separately.
resUlTs
Tests in subjects and controls did not show any significant 
deviation from HWE for any of the SNPs (data not shown). 
Analyzing the rs2476601 SNP within the PTPN22 gene revealed 
no polymorphism in the Japanese (15). Table 1 shows the allele 
and genotype frequencies of four SNPs at the two risk loci (1p13 
and 4q27) in AITD patients and controls. SNP rs7679475 (A/G) 
within the GPR103 gene showed significant association with HT. 
The G allele of rs7679475 was present in 22.9% of HT patients 
and 30.2% of controls [P =  0.023, OR =  0.69, 95% confidence 
interval (CI): 0.4976–0.9495], and the distribution of genotype 
frequencies differed significantly between HT patients and con-
trols (P = 0.046). There were no significant associations between 
HT and other three SNPs. GD showed no significant associations 
with any SNPs.
TaBle 1 | case–control association results for the four snPs at the two risk loci (1p13 and 4q27).














P valuea (Or) 
hT vs. control
rs2358994 1p13 BCL2L15 A 257 (57.1) 481 (53.8) 301 (54.3) 180 (52.9)
G 193 (42.9) 413 (46.2) 0.25 253 (45.7) 0.38 160 (47.1) 0.24
A/A 73 (32.4) 130 (29.1) 84 (30.3) 46 (27.1)
A/G 111 (49.3) 221 (49.4) 131 (48.0) 88 (51.8)
G/G 41 (18.2) 96 (21.5) 0.51 60 (21.7) 0.62 36 (21.2) 0.48
rs2153977 1p13 MAGI3 T 269 (59.8) 506 (56.6) 319 (57.6) 187 (55.0)
C 181 (40.2) 388 (43.4) 0.27 235 (42.4) 0.48 153 (45.0) 0.18
T/T 84 (37.3) 144 (32.2) 94 (33.9) 50 (29.4)
T/C 101 (44.9) 218 (48.8) 131 (47.3) 87 (51.2)
C/C 40 (17.8) 85 (19.0) 0.42 52 (18.8) 0.73 33 (19.4) 0.25
rs1111695 1p13 PHTF1 T 83 (18.4) 186 (20.8) 114 (20.6) 72 (21.2)
G 367 (81.6) 708 (79.2) 0.31 440 (79.4) 0.40 268 (78.8) 0.34
T/T 12 (5.3) 27 (6.0) 17 (6.1) 10 (5.9)
T/G 59 (26.2) 132 (29.5) 80 (28.9) 52 (30.6)
G/G 154 (68.4) 288 (64.4) 0.59 180 (65.0) 0.72 108 (63.5) 0.59
rs7679475 4q27 GPR103 A 314 (69.8) 660 (73.8) 398 (71.8) 262 (77.1)
G 136 (30.2) 234 (26.2) 0.12 156 (28.2) 0.47 78 (22.9) 0.023 (0.69)b
A/A 109 (48.4) 242 (54.1) 144 (52.0) 98 (57.6)
A/G 96 (42.7) 176 (39.4) 110 (39.7) 66 (38.8)
G/G 20 (8.9) 29 (6.5) 0.28 23 (8.3) 0.73 6 (3.5) 0.046c
Values given are the number of subjects, with the percentage in parentheses.
SNP, single-nucleotide polymorphism; CHR, chromosome; OR, odds ratio.
aP-value based on χ2 distribution.
bThe distribution of allele frequencies differed significantly between HT patients and controls.
cThe distribution of genotype frequencies differed significantly between HT patients and controls.
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Since cell-mediated immunity plays a central role in the 
pathogenesis of GO, similar to Crohn’s disease and rheumatoid 
arthritis (16), we tested the four SNPs for association with the 
subset of our GD patients that had GO (Table 2). SNP rs2358994 
(A/G) within the B-cell lymphoma 2-like protein 15 (BCL2L15) 
gene was associated with GO compared with controls (P = 0.018, 
OR = 1.52, 95% CI: 1.08–2.16) and GD without GO (P = 0.012, 
OR = 1.58, 95% CI: 1.10–2.27) (Table 2). The G allele of rs2358994 
was present in 53.4% of GO patients and 42.9% of controls 
(P = 0.018, OR = 1.52, 95% CI: 1.08–2.16), and the distribution of 
genotype frequencies differed significantly between GO patients 
and controls (P = 0.033). There were no significant associations 
between GO and other three SNPs. These data suggested that the 
BCL2L15 gene may be associated with GO.
DiscUssiOn
In this study, we replicated the association of the G allele of the 
rs7679475 (A/G) SNP within the GPR103 gene with HT in Japanese 
population. It should be noted that a locus on chromosome 4q27 
that is approximately 625 kB downstream the GPR103 gene was 
previously reported to be associated with T1D (17), as well as 
with other autoimmune diseases, including rheumatoid arthritis 
(18), Celiac disease (19), and ulcerative colitis (20). However, 
there was no association between rs7679475 and GD. Tomer 
et  al. (11) previously tested the two GPR103 SNPs (rs1513695, 
and rs7679475) showing association with APS3v, for association 
with AITD in their AITD dataset. The analysis showed that the 
two SNPs were both associated with HT, but not with GD (11). 
Our data and the data of Tomer et al. suggested that the GPR103 
gene may contribute to the pathogenesis of HT in Caucasian and 
Japanese patients. The GPR103 gene (also designated as QRFPR 
gene) is a G-protein-coupled receptor that is expressed not only 
in brain but also in human pancreatic islets, and it may have an 
effect on insulin secretion (21). The ligand for GPR103 (P518) 
is expressed in thyroid cells (22). Therefore, the mechanism by 
which the GPR103 gene may predispose to thyroid autoimmunity 
is still unclear.
The frequency of the G allele of the rs2358994 (A/G) was 
also found to be associated with GO in Japanese. The GWAS 
in patients with APS3v (11) mapped four genes (BCL2L15, 
MAGI3, PHTF1, and PTPN22) that are located in the same 
locus on chromosome 1p13 and are in linkage disequilibrium 
(LD) (11). Since the rs2476601 SNP within the PTPN22 gene 
revealed no polymorphism in the Japanese (15), we tested 
three additional SNPs in this locus (rs2358994, rs2153977, and 
rs1111695) for association with AITD. Although both GD and 
HT showed no significant associations with any of these SNPs, 
there was a significant association between GO and rs2358994, 
suggesting that the BCL2L15 gene may be a GO-specific gene 
in Japanese. SNP rs2358994 showed significant association only 
with GO, but not with GD without GO. This SNP is located 
within the BCL2L15 gene, which is in tight LD with PTPN22 (11). 
Therefore, at present, we cannot determine if this association 
reflects an association with the BCL2L15 gene, PTPN22 gene, or 
another gene within this locus, and further studies are needed 
to determine that.
The BCL2L15 gene (also designated as BFK gene) is a proapop-
totic member of the BCL2 family (23, 24). Reduction in BCL2L15 
protein expression is observed in gastrointestinal tumors (25). 














P valuea (Or)  
gO vs. gD  
without gO
P valuea (Or)  
gD without  
gO vs. control
rs2358994 A 257 (57.1) 301 (54.3) 83 (46.6) 218 (58.0)
G 193 (42.9) 253 (45.7) 95 (53.4) 158 (42.0) 0.018 (1.52)b 0.012 (1.58)d 0.80
A/A 73 (32.4) 84 (30.3) 16 (18.0) 68 (36.2)
A/G 111 (49.3) 133 (48.0) 51 (57.3) 82 (43.6)
G/G 41 (18.2) 60 (21.7) 22 (24.7) 38 (20.2) 0.033c 0.0086e 0.51
rs2153977 T 269 (59.8) 319 (57.6) 94 (52.8) 225 (59.8)
C 181 (40.2) 235 (42.4) 84 (47.2) 151 (40.2) 0.11 0.12 0.99
T/T 84 (37.3) 94 (33.9) 28 (31.5) 66 (35.1)
T/C 101 (44.9) 131 (47.3) 38 (42.7) 93 (49.5)
C/C 40 (17.8) 52 (18.8) 23 (25.8) 29 (15.4) 0.25 0.12 0.63
rs1111695 T 83 (18.4) 114 (20.6) 38 (21.3) 76 (20.2)
G 367 (81.6) 440 (79.4) 140 (78.7) 300 (79.8) 0.41 0.76 0.52
T/T 12 (5.3) 17 (6.1) 8 (9.0) 9 (4.8)
T/G 59 (26.2) 80 (28.9) 22 (24.7) 58 (30.9)
G/G 154 (68.4) 180 (65.0) 59 (66.3) 121 (64.4) 0.49 0.28 0.58
rs7679475 A 314 (69.8) 398 (71.8) 122 (68.5) 276 (73.4)
G 136 (30.2) 156 (28.2) 56 (31.5) 100 (26.6) 0.76 0.23 0.25
A/A 109 (48.4) 144 (52.0) 42 (47.2) 102 (54.3)
A/G 96 (42.7) 110 (39.7) 38 (42.7) 72 (38.3)
G/G 20 (8.9) 23 (8.3) 9 (10.1) 14 (7.4) 0.94 0.50 0.49
Values given are the number of subjects, with the percentage in parentheses.
SNP, single nucleotide polymorphism; OR, odds ratio.
aP-value based on χ2 distribution.
bThe distribution of allele frequencies differed significantly between GO patients and controls.
cThe distribution of genotype frequencies differed significantly between GO patients and controls.
dThe distribution of allele frequencies differed significantly between GD with and without GO patients.
eThe distribution of genotype frequencies differed significantly between GD with and without GO patients.
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Interestingly, higher levels of the BCL2 protein was registered 
in freshly isolated Crohn’s disease patient polymorphonuclear 
neutrophils, in contrast to controls, in which BCL2 protein was 
undetectable (26). These data suggest that the defective func-
tionality of neutrophils can be the early event responsible for the 
altered mucosal immune response in Crohn’s disease, which is 
one of the autoimmune diseases.
There are two limitations of the present study. First, the num-
ber of samples is relatively small that may have limited our ability 
to identify common variants with weak effects. Second, controls 
selection process may be insufficient. However, all the controls 
have been screened for T3/T4 of other thyroid-related pheno-
types. Also, all study participants lived in the Tokyo metropolitan 
area. Moreover, quality control (QC) testing, including testing 
for HWE, was performed using SNPALyze ver. 7.0 (http://www.
dynacom.co.jp/e/products/package/snpalyze/). Tests in subjects 
and controls did not show any significant deviation from HWE 
for any of the SNPs.
In conclusion, we replicated an association between HT and 
the G allele of rs7679475 within the GPR103 gene in Japanese. 
These results suggest the GPR103 gene may contribute to the 
pathogenesis of HT in both Caucasians and Japanese. We also, 
for the first time, identified the association of SNP rs2358994 
within BCL2L15 gene with GO in the Japanese population, 
suggesting genetic influences in different ethnic populations 
(27). Studies with ethnically diverse populations, including large 
numbers of patients, are needed to confirm the role of above two 
genes in AITD.
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